Industry News

Industry News

DNA Computation Performed In Living Cells

Jul 15, 2013

Chemists from North Carolina State University have performed a DNA-based logic-gate operation within a human cell. The research may pave the way to more complicated computations in live cells, as well as new methods of disease detection and treatment... Read More

Molecular Discovery Puts Cancer Treatment In A New Perspective

Jul 15, 2013

Researchers from the University of Copenhagen and the National Institutes of Health have obtained ground-breaking new knowledge about proteases - important enzymes which, among other things, play a role in the development of cancer cells. The findings may be significant for the development of cancer drugs, and have just been published in Journal of Biological Chemistry... Read More

Study: Women Who Survived Childhood Cancer Still Have Good Chance Of Conceiving

Jul 14, 2013

Researchers have found that although females who survived cancer in their childhood have an increased risk of infertility, they still have a good chance of conceiving. The study, published in The Lancet Oncology, revealed that around two-thirds of women who suffered from childhood cancer become pregnant... Read More

Researchers Discover A Role For A Protein That Has Implications For Treatment Of Cancer And Heart Disease

Jul 14, 2013

St. Jude Children's Research Hospital scientists have discovered that a protein used by cancer cells to evade death also plays a vital role in heart health. This dual role complicates efforts to develop cancer drugs that target the protein, but may lead to new therapies for heart muscle damage. The research appeared in a recent edition of the scientific journal Genes & Development... Read More

Researchers Develop New Method For Tracking Cell Signaling

Jul 14, 2013

Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments... Read More

Late Stage Lung Cancer Drug Gilotrif (Afatinib) Approved By FDA

Jul 13, 2013

The FDA has approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone... Read More

FDA Approves New Drug "Gilotrif" For Patients With Non-Small Cell Lung Cancer

Jul 13, 2013

The FDA has just approved the use of Gilotrif (afatinib) to treat patients with non-small cell lung cancer (NSCLC) who have certain epidermal growth factor receptor (EGFR) gene mutations in their tumors. Lung cancer is one of the leading cancer-killers, with an estimated 159,480 people dying from the disease this year in the U.S. alone... Read More

New Approach Could Enhance Cancer Drug Delivery

Jul 13, 2013

Researchers have developed a concept to potentially improve delivery of drugs for cancer treatment using nanoparticles that concentrate and expand in the presence of higher acidity found in tumor cells... Read More

Belly Fat Tied to Raised Heart and Cancer Risks

Jul 12, 2013

Carrying too much fat around the abdomen puts people at greater risk for heart disease and cancer compared with people who have a similar body mass index (BMI) but who carry their fat in other parts of the body. So says a US study published online in the July issue of the Journal of the American College of Cardiology... Read More

New Treatment For Management Of Advanced Prostate Cancer After First-Line Hormonal Treatments And Docetaxel Chemotherapy Failure, Available In UK

Jul 12, 2013

Available now, XTANDI TM (enzalutamide) has been licensed for the treatment of men with advanced prostate cancer whose disease has become resistant to first-line hormonal treatments and has progressed following docetaxel chemotherapy[i], marking an important step in managing prostate cancer, which is the most common cancer among males in the UK... Read More

Previous Page   Next Page